Origins and Benefits of Biologically Active Components in Human Milk
Origins and Benefits of Biologically Active Components in Human Milk
批准号:
10683486
负责人:
Lars Bode
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-06-01 至 2024-05-31
关键词:
AcademiaAddressAffectAgeAwardBig DataBiologyBrainCategoriesCharacteristicsChild NutritionCognitionCollaborationsCommunicable DiseasesDevelopmentDiseaseEnsureFloridaFutureGoalsGovernmentHuman MilkHypersensitivityImmuneIndustryInfantInfant HealthInfant formulaLactationLengthMammary glandMaternal HealthMembraneMetabolic DiseasesMothersNational Institute of Allergy and Infectious DiseaseNational Institute of Child Health and Human DevelopmentNational Institute of Diabetes and Digestive and Kidney DiseasesNatureNutrientOligosaccharidesOralPersonsPoliciesPregnancyPremature InfantPropertyResearchResearch PersonnelSafetyScienceSourceStrategic PlanningStudentsTravelUnderrepresented PopulationsUnited States National Institutes of Healthcareercareer developmentcollaborative environmentcomplex biological systemseffective therapygut healthimprovedinnovationinterestmilk fat globulemother nutritionnext generationnovelnutritionpostersprofessional studentssymposiumtechnological innovationtechnology development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The 5th FASEB Science Research Conference (SRC) on “Origins and Benefits of Biologically
Active Components in Human Milk” in Melbourne, Florida, June 4-9, 2023, will be a gathering of
professionals who wish to deepen their understanding of this scientific topic. The conference will
bring together previous and new speakers/attendees to promote diversity of thought in this space.
The conference has a strong inter-disciplinary nature, with stakeholders from industry, academia
and government coming together to better understand human milk as a complex biological
system with the ultimate goal of improving maternal & infant health.
A majority of the conference sessions will address key scientific research themes and objectives
outlined in the NICHD Strategic Plan 2020: “Of unique interest to the institute [NICHD] is a better
understanding of the composition and function of human milk, the effect of maternal nutrition and
length of gestation on human milk composition and lactation, and the optimal source of nutrition
and mode if nutrient delivery to the infant, especially preterm infants.” In addition, the conference
addresses one of the ten aspirational goals in the NICHD Strategic Plan 2020: “Optimize infant
survival by synthesizing human milk, capturing all its components and properties, and
individualizing it to the characteristics of the infant’s mother.”
Understanding the origins and benefits of human milk components is also relevant to NIH
institutes other than NICHD as they affect gut health and development and metabolic diseases
(NIDDK) and protect from allergy and infectious diseases (NIAID). In fact, human milk
components may serve as templates for novel, safe and effective treatments for diseases in
people of all ages and, therefore, be of relevance to many of the other NIH institutes.
Finally, the conference will offer a strong “career development” focus, supporting students and
early career investigators with their professional ambitions. We therefore specifically aim to
subsidize registration and travel of invited speakers in the early career investigator category and
provide travel awards for students with outstanding abstracts, posters and oral presentations.
Supporting the next generation of researchers, clinicians and educators in the field of human milk
and lactation will ensure that NICHD’s current objectives and aspirational goals will be met not
only today, but also in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Milk Analytics Core
-
批准号:10487510
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10681290
-
项目类别:
-
资助金额:$123.91万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Milk Analytics Core
-
批准号:10681304
-
项目类别:
-
资助金额:$20.26万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Exploring Associations between Human Milk Oligosaccharides and Atherosclerosis Risk Factors in Infancy and Early Childhood
-
批准号:10195374
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Exploring Associations between Human Milk Oligosaccharides and Atherosclerosis Risk Factors in Infancy and Early Childhood
-
批准号:10491367
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10659295
-
项目类别:
-
资助金额:$101.57万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10309708
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Milk Analytics Core
-
批准号:10309713
-
项目类别:
-
资助金额:$20.51万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses
-
批准号:10487493
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2021
-
负责人:Lars Bode
-
依托单位:
Exploring human milk oligosaccharides and malaria risk in breastfed infants
-
批准号:10226366
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2020
-
负责人:Lars Bode
-
依托单位:
Exploring human milk oligosaccharides and malaria risk in breastfed infants
-
批准号:10057627
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2020
-
负责人:Lars Bode
-
依托单位:
Exploring Associations between Human Milk Oligosaccharides and Growth, Body Composition and Obesity Risk in Infancy and Early Childhood
-
批准号:9317205
-
项目类别:
-
资助金额:$23.26万
-
财政年份:2017
-
负责人:Lars Bode
-
依托单位:
Exploring Oligosaccharide Synthesis in Human Mammary Gland Epithelial Cells
-
批准号:8892907
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2015
-
负责人:Lars Bode
-
依托单位:
Disialyl oligosaccharides as Necrotizing Enterocolitis therapeutics
-
批准号:9048196
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:Lars Bode
-
依托单位:
Selective Inhibitors of Plasmodium Falciparum G6PD as Novel Antimalarials
-
批准号:8911238
-
项目类别:
-
资助金额:$39.8万
-
财政年份:2014
-
负责人:Lars Bode
-
依托单位:
Selective Inhibitors of Plasmodium Falciparum G6PD as Novel Antimalarials
-
批准号:8632677
-
项目类别:
-
资助金额:$41.47万
-
财政年份:2014
-
负责人:Lars Bode
-
依托单位:
Screening for Human Milk Oligosaccharides that Protect Infants from HIV Infection
-
批准号:8090034
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:Lars Bode
-
依托单位:
Fusing Glycobiology and Nutritional Sciences to Prevent Necrotizing Enterocolitis
-
批准号:8119080
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:Lars Bode
-
依托单位:
Identification of G6PD inhibitors for the development of novel antimalarial drugs
-
批准号:7905094
-
项目类别:
-
资助金额:$23.34万
-
财政年份:2009
-
负责人:Lars Bode
-
依托单位:
Fusing Glycobiology and Nutritional Sciences to Prevent Necrotizing Enterocolitis
-
批准号:7924735
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Lars Bode
-
依托单位:
海外基金